• 1
    Andrews RK, Lopez JA, Berndt MC. Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol 1997; 29:91105. Medline
  • 2
    Anti-Platelet Trialists' Collaborative Study. Collaborative over-view of randomised trials of anti-platelet therapy I: prevention of death, myocardial infarction and stroke by prolonged anti-platelet therapy in various categories of patients. Br Med J 1994; 308:81106.
  • 3
    Armstrong SH, Budka MJE, Morrison KC, Hasson M. Preparation and properties of serum and plasma proteins. The refractive properties of the proteins of human plasma and certain purified fractions. J Am Chem Soc 1947; 69:17471753.
  • 4
    Barer R, Joseph S. Refractometry of living cells. Q J Microscop Sci 1954; 95:399423.
  • 5
    Barnes JL. Platelets in glomerular disease. 1997; Nephron 77:378393. Medline
  • 6
    Berk BC, Alexander RW, Brock TA, Gimbrone MA Jr. Webb RC. Vasoconstriction: a new activity for platelet derived growth factor. Science 1986; 232:8790. Medline
  • 7
    Braque P, Touqui L, Shen TS, Vargaftig BB: Perspectives in platelet activating research. Pharm Rev 1987; 39:97145. Medline
  • 8
    Cahill MR, Macey MG, Newland AC. Correlation of GP53 and P-selectin expression in myeloproliferative disorders and normal controls. Blood Coagul Fibrinol 1996; 7:169171. Medline
  • 9
    Cahill MR, Macey MG, Newland AC. Platelet surface activation antigen expression at baseline and during elective angioplasty in patients with mild to moderate coronary artery disease. Blood Coagul Fibrinol 1996; 7:165168. Medline
  • 10
    Capron A, Joseph M, Ameisen JC. Platelets as effectors in immune and hypersensitivity reactions. Int Archs Allergy Appl Immun 1987; 82:307312.
  • 11
    Chapman ES, Lerea KM, Kirk R, Sorette MP, Sanjay NS, Zelmanovic D. Monitoring in vitro and ex vivo platelet activity: comparison of alpha granule release, density distribution, platelet adhesion and mean platelet component concentration (MPC). Blood 1998; 92 :(10, Suppl. 1): 68B, Abst 3273.
  • 12
    Corash L, Tan H, Gralnick H. Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure. Blood 1977; 49:7187. Medline
  • 13
    Collins CE, Cahill MR, Newland AC, Rampton DS: Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994; 106:840845. Medline
  • 14
    Davies TA, Long HJ, Tibbles HE, Sgro KR, Wells JM, Rathbun WH, Seetoo KF, McMenamin ME, Smith SJ, Feldman RG, Levesque CA, Fine RE, Simons ER. Moderate and advanced Alzheimer's patients exhibit platelet activation differences. Neurobiol Ageing 1997; 18:155162.
  • 15
    Deuel TF, Senior RM, Chang D. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci USA 1981; 78:45844587. Medline
  • 16
    Deuel TF, Senior RM, Huang JS, Griffin GL. Chemotaxis of monocytes and neutrophils to platelet derived growth factor. J Clin Invest 1982; 69:10461049. Medline
  • 17
    ETDRS Investigators. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy study report 14. JAMA 1992; 268:12911300.
  • 18
    Goetzl EJ, Woods JM, Gorman RR. Stimulation of human eosinophils and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. J Clin Invest 1977; 59:179181. Medline
  • 19
    Goodall AH, Macey MG. Platelet associated molecules and immunoglobulins. In: MacyMG, editor. Flow cytometry clinical applications. London: Blackwell, 1994. p 148191.
  • 20
    Jackson SR, Carter JM. Platelet volume: laboratory measurement and clinical application, blood reviews. Haemost Thromb 1993; 7:104113.
  • 21
    Kuhne T, Hornstein A, Semple J, Chang W, Blanchette V, Freedman J. Flow cytometric evaluation of platelet activation in blood collected into EDTA vs. Diatube-H, a sodium citrate solution supplemented with theophylline, adenosine, and dipyridamole. Am J Hematol 1995; 50: 4045. Medline
  • 22
    Kim YR, Ornstein L. Isovolumetric sphering of erythrocytes for more accurate and precise cell volume measurements by flow cytometry. Cytometry 1983; 3:419427. Medline
  • 23
    Knight CJ, Panesar M, Wright C, Clarke D, Butowski PS, Patel D, Patrineli A, Fox K, Goodall AH. Altered platelet function detected by flow cytometry. Effects of coronary artery disease and age. Arterioscl Thromb Vascular Biol 1997; 17:20442053. Medline
  • 24
    Konijnenberg A, van der Post JA, Mol BW, Schaap MC, Lazarov R, Bleker OP, Boer K, Sturk A. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study. Am J Obstet Gynecol 1999; 177:434442.
  • 25
    McShine RL, Das FPC, Siblinga CS, Brozovic B. Differences between the effects of EDTA and citrate anti-coagulants of platelet count and mean platelet volume. Clin Lab Haematol 1990; 12:277285. Medline
  • 26
    Mullaney PF, Van Dilla MA, Coulter JR, Dean PN. Cell sizing: a light scattering photometer for rapid volume determination. Rev Sci Instrum 1969; 40:10291032. Medline
  • 27
    Okada M, Sagawa T, Tominaga A, Kodama T, Hitsumoto Y. Two mechanisms for platelet-mediated killing of tumour cells: one cyclo-oxygenase dependent and the other nitric oxide dependent. Immunology 1996; 89:158164. Medline
  • 28
    Pidard D, Didry D, Kunicki TJ, Nurden AT. Temperature-dependent effects of EDTA on the membrane glycoprotein IIb/IIIa complex and platelet aggregability. Blood 1986; 67:604611. Medline
  • 29
    Schror K. Antiplatelet drugs. A comparative review. Drugs 1995; 50: 728. Medline
  • 30
    Sibai BM, Caritis SN, Thom E. The National Institute of Child Health and Human Development Network of Maternal Fetal Medicine Units. Prevention of pre-eclampsia with low dose aspirin in healthy nulliparous pregnant women. N Engl J Med 1989; 329:351356.
  • 31
    Thibert V, Bellucci S, Cristofari M, Gluckman E, Legrand C. Increased platelet CD36 constitutes a common marker in myeloproliferative disorders. Br J Haematol 1995; 91:618624. Medline
  • 32
    Tschoepe D, Driesch E, Schwippert B, Lampeter EF. Activated platelets in subjects at increased risk of IDDM. Diabetologia 1997; 40:573577. Medline
  • 33
    Tycko DH, Metz MH, Epstein EA, Grinbaum A. Flow cytometric light scattering measurement of red cell volume and hemoglobin concentration. Appl Optics 1985; 24:13551360.
  • 34
    Vanden Bossche H. Ridogrel: a selective inhibitor of the cytochrome P450-dependent thromboxane synthesis. Biochem Pharmacol 1992; 43:739744. Medline
  • 35
    Wahl SM, Hunt DA, Wakefield LM. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987; 63:943945.
  • 36
    Zelmanovic D, Colella GM, Hetherington EJ, Chapman ES, Paseltiner L. Automated method and device for identifying and quantifying platelets and for determining platelet activation state using whole blood samples. U.S. Patent Number 5,817,519, October 6, 1998.